Yukon Choice Flex Sirolimus Eluting Coronary Stent System
World's Longest Studied Drug Eluting Stent
New generation DES providing synergy of Biodegradable Polymer with microporous surface to enhance optimal performance.
Optimal Drug Release
- Microporous Surface- Small pores on the stent surface ensures optimum drug release with minimal use of polymer.
- Shellac Resin (Wax-free) ensures better polymer-drug binding with negligible polymer flaking during stent expansion.
Better Endothelialisation & Superior Strut Coverage
- Abluminal Coating- Drug polymer matrix coated only on the abluminal side for drug release only to target tissue.
- No polymer on the luminal side ensures healthy endothelialization
Clinical Studies
In this unique long term analysis at 10 years, Yukon has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.
Comparison of clinical outcomes at 10 years in patients treated with new-generation BP-SES versus new-generation PP-EES versus early generation SES.
*As per Clinical data with SS stent using similar microporous surface and drug coating technology
